1-15 of 25
Incorporating Novel Muscarinic Agents for Schizophrenia Into Clinical Practice: Overcoming Clinical Inertia
CME/CE Virtual EventIncorporating Novel Muscarinic Agents for Schizophrenia Into Clinical Practice: Overcoming Clinical Inertia
May 28, 2026
07:00 AM - 08:00 AM ET
Rethinking Schizophrenia Treatment Through Muscarinic Modulation
CME/CERethinking Schizophrenia Treatment Through Muscarinic Modulation
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
CME/CEMuscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
Updates in Major Depressive Disorder with Insomnia
CME/CEUpdates in Major Depressive Disorder with Insomnia
- advertisement
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
CME/CEAre All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
From Resistance to Response: Evolving Strategies in MDD Management
CME/CE Broadcast ReplayFrom Resistance to Response: Evolving Strategies in MDD Management
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
MinuteCE®Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
- advertisement
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
MinuteCE®QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
Optimizing VNS Parameters: Keys to Therapeutic Success
MinuteCE®Optimizing VNS Parameters: Keys to Therapeutic Success
The Safety of Sodium Oxybate in Treating Narcolepsy
CME/CEThe Safety of Sodium Oxybate in Treating Narcolepsy













































